Form 8-K - Current report:
SEC Accession No. 0001564590-20-015911
Filing Date
2020-04-08
Accepted
2020-04-08 16:25:15
Documents
13
Period of Report
2020-04-02
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K idxx-8k_20200402.htm   iXBRL 8-K 54850
2 GRAPHIC ge3r34bsh01u000001.jpg GRAPHIC 2144
  Complete submission text file 0001564590-20-015911.txt   187251

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA idxx-20200402.xsd EX-101.SCH 5764
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE idxx-20200402_lab.xml EX-101.LAB 18710
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idxx-20200402_pre.xml EX-101.PRE 11166
12 EXTRACTED XBRL INSTANCE DOCUMENT idxx-8k_20200402_htm.xml XML 3420
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 20782212
SIC: 2835 In Vitro & In Vivo Diagnostic Substances